Editing Devils to Fight Cancer | Canberra News

Scientists are racing against time to save the Tasmanian devil from a lethal facial tumor disease by genetically editing out a cancer-linked gene, with a potential vaccine trial set for 2026. Backed by the University of Tasmania and Colossal, the project aims to replace the problematic gene with one from a related species, like the fat-tailed dunnart. While releasing edited devils into the wild is still years away, conservationists see this bold genetic intervention as a lifeline for the species, backed by rigorous testing and strong support from wildlife advocates. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/935908385cc27bf7